Enamine to Enable Access to Selected Pfizer Reference Compounds to Support the Global Research Community

KYIV, UKRAINE, May 26, 2025 /EINPresswire.com/ -- Enamine, the leading provider of chemical compounds and drug discovery services, today announced certain reference compounds from Pfizer are now available through Enamine`s marketplace and Enamine`s integration capabilities (i.e. punchout site, hosted catalogs, and API solutions). This allows researchers to explore and purchase from the catalog of selected Pfizer-provided drugs, chemical dormants, investigational compounds, and isotope-labelled molecules with appropriate quality control.

Iryna Yavnyuk, CEO of Enamine US, Inc. comments: “For over 30 years, Enamine has remained the world’s leading provider of small molecules, having the largest in-stock catalog of screening compounds and building blocks. Our goal has remained the same over the years: support research programs around the world to contribute to global science. Having added selected Pfizer-provided compounds to our offerings, we will make sure our customers will have access to a broader diversity of chemicals in one place.”

𝐀𝐛𝐨𝐮𝐭 𝐄𝐧𝐚𝐦𝐢𝐧𝐞: Enamine is a scientifically driven integrated discovery Contract Research Organisation with unique partnering opportunities in exploring new chemical space. The company combines access to the in-house produced screening compounds (4.5M in stock) and building blocks (350K in stock) with a comprehensive platform of integrated discovery services to advance and accelerate the efforts in Drug Discovery. For more information visit: https://enamine.net

Iryna Yavnyuk
Enamine
email us here